Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jun;5(3):372-375.
doi: 10.1002/ehf2.12276. Epub 2018 Feb 20.

Chloroquine-induced cardiomyopathy: a reversible cause of heart failure

Affiliations
Case Reports

Chloroquine-induced cardiomyopathy: a reversible cause of heart failure

Haran Yogasundaram et al. ESC Heart Fail. 2018 Jun.

Abstract

Chloroquine (CQ) and hydroxychloroquine (HCQ) are anti-rheumatic medications frequently used in the treatment of connective tissue disorders. We present the case of a 45-year-old woman with CQ-induced cardiomyopathy leading to severe heart failure. Electrocardiographic abnormalities included bifascicular block, while structural disease consisted of severe biventricular and biatrial hypertrophy. Appropriate diagnosis via endomyocardial biopsy led to cessation of CQ and subsequent dramatic improvement in symptoms and structural heart disease. Cardiac toxicity is an under-recognized adverse effect of CQ/HCQ leading to cardiomyopathy with concentric hypertrophy and conduction abnormalities, with the potential for significant morbidity and mortality. Predisposing factors for CQ/HCQ-induced cardiomyopathy have been proposed. CQ/HCQ cardiomyopathy is a phenocopy of Fabry disease, and α-galactosidase A polymorphism may account for some heterogeneity of disease presentation.

Keywords: Cardiac MRI; Cardiomyopathy; Chloroquine; Heart failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electrocardiogram on initial admission demonstrating conduction abnormalities (bifascicular block) with signs of biventricular hypertrophy.
Figure 2
Figure 2
Cardiac magnetic resonance imaging prior to discontinuation of chloroquine (A), with biventricular hypertrophy and biatrial dilatation shown on two‐chamber (A1), three‐chamber (A2), four‐chamber (A3), and short‐axis (A4) views. Cardiac magnetic resonance imaging was performed after cessation of chloroquine (B), demonstrating significant resolution of structural abnormalities shown on two‐chamber (B1), three‐chamber (B2), four‐chamber (B3), and short‐axis (B4) views.
Figure 3
Figure 3
Pathology images of endomyocardial biopsy specimen. Light microscopy using haematoxylin and eosin stain demonstrates vacuolization of cardiomyocytes at ×200 magnification (A); light microscopy using periodic acid–Schiff stain at ×400 magnification shows that the vacuoles are periodic acid–Schiff‐negative (B); electron microscopy at ×25 500 magnification demonstrates myeloid and curvilinear myeloid bodies, as well as vacuolated cytoplasm characteristic of chloroquine‐associated cardiomyocyte damage (C).

References

    1. Page RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J. Drugs that may cause or exacerbate heart failure. Circulation 2016; 134: e32‐e69. - PubMed
    1. Eschenhagen T, Force T, Ewer MS, Keulenaer GW, Suter TM, Anker SD, Avkiran M, Azambuja E, Balligand JL, Brutsaert DL. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2011; 13: 1–10. - PubMed
    1. Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY. Hydroxychloroquine‐induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol 2014; 30: 1706–1715. - PubMed
    1. Ferrari R, Böhm M, Cleland JG, Paulus WJ, Pieske B, Rapezzi C, Tavazzi L. Heart failure with preserved ejection fraction: uncertainties and dilemmas. Eur J Heart Fail 2015; 17: 665–671. - PubMed
    1. Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB. Hydroxychloroquine‐induced cardiomyopathy in systemic lupus erythematosus. J Clin Rheumatol: Practical Reports on Rheumatic & Musculoskeletal Diseases 2016; 22: 287–288. - PubMed

Publication types

Grants and funding

LinkOut - more resources